Ortho diagnostics reagents
Ended Purchase Order Awarded Last action
- Contract number
- HT941024P0004
- Awardee
-
Quidelortho Sales Company, LLC UEI ZFXRG96JMJ39
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $227,595
Award facts
- Opportunity
-
- Notice of Intent to Sole Source Ortho-Clinical Diagnostics Reagents and Consumables for Naval Hospital Okinawa Pre-Solicitation · HT941023N0074 · Posted Aug 14, 2023
- Contract value 48% obligated
-
- $376,698.73 Current, with exercised options
- $475,370.41 Potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- Contracting staff
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- San Diego, CA 92121, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $8,960 | |
| Supplemental Agreement for work within scope | $39,280 | |
| Vendor DUNS or Name Change - Non-Novation | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Funding Only Action | $92,768 | |
| Exercise an Option | $0 | |
| Supplemental Agreement for work within scope | $49,276 | |
| Supplemental Agreement for work within scope | $37,312 | |
| Original award | $0 |
About this award
The Defense Health Agency awarded a firm-fixed-price purchase order to Quidelortho Sales Company, LLC on October 17, 2023, with a ceiling value of $475,370.41 for Ortho diagnostics reagents and Ortho reagents and supplies. The award carried no set-aside. The prime is a HUBZone-certified joint venture and child entity of Ortho-Clinical Diagnostics, Inc. Place of performance is San Diego, California, and the order runs through September 30, 2028.
The originating pre-solicitation, posted August 14, 2023 with a due date of August 29, 2023, announced the Defense Health Agency Contracting Activity's intent to award a sole-source supply contract to Ortho-Clinical Diagnostics, Inc. for Ortho reagents and consumables supporting the U.S. Naval Hospital Okinawa Armed Services Blood Bank Center. That notice described a base year from November 21, 2023 through September 20, 2024, four option years, and monthly dropship delivery directly to the hospital. Covered items included MTS Ortho reagents and consumables and reagents compatible with the Ortho Vision Immunohematology Analyzer.
Quick answers
Who was awarded contract HT941024P0004?
HT941024P0004 was awarded to Quidelortho Sales Company, LLC by Defense Health Agency (Department of Defense) on October 17, 2023.
How much is contract HT941024P0004 worth?
The government has obligated $227,595 on HT941024P0004. Its current value, with exercised options, is $376,699. Its potential value, with all options, is $475,370.
Was contract HT941024P0004 competed?
The extent of competition for HT941024P0004 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award